Infectious Diseases (PGY-2)

The Infectious Diseases (PGY-2) specialty residency provides the resident with a robust experience in management of patients with infectious diseases across multiple different inpatient service lines including: infectious diseases consults, medical and surgical intensive care, cardiothoracic surgery, and emergency medicine. This goal of this program is for the resident to become well-versed in the multiple facets of infectious diseases, microbiology, and antimicrobial stewardship. The program is accredited by the American Society of Health-System Pharmacists.

As a member of the health care team, the resident assumes responsibility and accountability for safe and appropriate patient-centered care at a large academic medical center. The resident is also involved in the academic, administrative, formulary management, and clinical drug research activities of the department.

Purpose and Goals

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

The Infectious Disease Pharmacy Practice Residency is an organized, directed postgraduate program that centers on developing a mastery of knowledge and an expert level of competency in infectious disease pharmacy practice. The goals of the UF Health Jacksonville PGY2 Infectious Diseases Residency Program are to develop the resident’s dedication and skills necessary to:

• be a specialized practitioner with the confidence, competence, and compassion necessary to provide complex medication recommendations that meets the needs of infectious disease patients
• be a fully integrated member of the interdisciplinary team
• provide safe, effective, and appropriate medication therapy to patients
• effectively educate patients/family members, students and health care professionals regarding infectious disease medication issues
• demonstrate leadership for infectious disease practice through participation in interdisciplinary committees and planning groups to improve care for patients
• conduct research in the infectious diseases environment to improve medication use and pharmacy practice

Program

Due to the active involvement of a highly skilled and motivated team of pharmacy practitioners with a variety of medical services, the resident is provided with a wide range of opportunities and experiences in the provision of patient care.

Program Structure

The residency program provides training in all aspects of infectious disease pharmacy practice. Residents will orient to the department of pharmacy and complete core, elective, and longitudinal learning experiences. Core and elective learning experiences are 4 or 8 weeks in duration. Longitudinal learning experiences are 52 weeks in duration.

• Orientation (4 weeks if new to UF Health Jacksonville, 2 weeks concurrent if early commit)
• Core Learning Experiences (7)
  • Antimicrobial Stewardship I (4 weeks)
  • Antimicrobial Stewardship II (4 weeks)
  • Critical Care (Pick 1)
    • Medical Critical Care I (4 weeks)
    • Surgical Critical Care I (4 weeks)
  • Infectious Diseases Consult Service I (8 weeks)
  • Infectious Diseases Consult Service II (8 weeks)
  • Infectious Diseases Consult Service III (4 weeks)
  • Microbiology (4 weeks)
• Required Longitudinal Learning Experiences (4)
  • Infectious Diseases Continuity Clinic (½ day/week)
  • Infectious Diseases Practice
  • Practice Coverage (staffing) (Inpatient: 16 hours every 3rd weekend)
  • Research Project
• Elective Learning Experiences (2)
  • Academia/Infectious Disease (4 weeks)
  • Cardiothoracic Surgery (4 weeks)
  • Emergency Medicine (4 weeks)
  • General Surgery (4 weeks)
  • Infectious Diseases Transplant (4 weeks, offsite)
  • Medical Critical Care I/II (4 weeks)
  • Neonatal Intensive Care (4 weeks)
  • Surgical/Trauma Critical Care I/II (4 weeks)
  • Trauma Surgery (4 weeks)
    Other elective learning experiences may be developed based on resident interest and preceptor availability

Program Director

Christopher A Jankowski, Pharm.D., BCPS, BCIDP

Program Length

52 weeks, beginning in July

Benefits

• Stipend - $56,500
• 27 days of leave
  • Personal leave - 7 days
  • Holidays - 6 days
  • Professional leave - ASHP Midyear meeting (3 days), Residency Research Conference (2 days), professional conference (5 days), interviews (5 days)
• Research days - 12 days
• Health insurance
• Dental coverage
• Life insurance
• Educational and professional travel allowances
• Dedicated office space
• Laptop

Application Requirements

Eligibility requirements for the residency program include the following:

• Graduate from an ACPE-accredited college or school of pharmacy with a Doctor of Pharmacy degree
• Completion of an ASHP-accredited Pharmacy (PGY-1) Residency
• Eligible for licensure in the State of Florida – all residents must take their exams prior to the start of the residency
• On-site interview
• For non-resident alien applicants, authorization for employment that is valid through the residency period is required

Application Materials

• Applicant information
• Letter of intent
• Current curriculum vitae
• Letters of recommendation from three (3) professional sources
• Official transcript of applicant’s pharmacy coursework and grades

The application deadline is January 5th.

Application materials should be submitted through PhORCAS.

Chase Cole, Pharm.D., BCCCP

J. Chase Cole, PharmD, BCCCP, is a clinical specialist in the Neurocritical Care Unit at UF Health Jacksonville and a Clinical Assistant Professor for the University of Florida College of Pharmacy. Dr. Cole received his PharmD from University of South Carolina in Columbia, South Carolina and completed both his PGY-1 pharmacy practice residency and PGY-2 specialty residency in critical care at UF Health Jacksonville. Dr. Cole is an active member of the Society of Critical Care Medicine, American Society of Health-System Pharmacists, and Florida Society of Health-System Pharmacists. His areas of interest include status epilepticus, intracranial pressure management, hemodynamics, infectious diseases, and pain and sedation management.

Christopher A Jankowski, Pharm.D., BCPS, BCIDP

Christopher A Jankowski, Pharm.D., BCPS, BCIDP is a clinical specialist in Infectious Diseases at UF Health Jacksonville, a Clinical Assistant Professor with the University of Florida College of Pharmacy, and a Courtesy Assistant Professor in the Department of Medicine, University of Florida College of Medicine - Jacksonville.

Dr. Jankowski received his Pharm.D. from the Ohio State University College of Pharmacy. He completed his Pharmacy Practice residency (PGY-1) at the Ohio State University Wexner Medical Center and specialty residency in Infectious Diseases (PGY-2) at the Ohio State University Wexner Medical Center.

Dr. Jankowski was awarded Preceptor of the Year by numerous organizations including Florida Society of Health-System Pharmacists, University of Florida College of Pharmacy and UF Health Jacksonville.

His areas of interest are in the translational research, antimicrobial stewardship, and resistant Gram-negative infections.

Danielle Sanchez, Pharm.D.

Danielle Sanchez, Pharm.D., is a clinical specialist in Infectious Diseases at UF Health Jacksonville and a Clinical Assistant Professor with the University of Florida College of Pharmacy.

Dr. Sanchez received her Pharm.D. from the University of Illinois at Chicago College of Pharmacy. She completed her Pharmacy Practice residency (PGY-1) at the University of Illinois at Chicago College of Pharmacy and specialty residency in Infectious Diseases (PGY-2) at Advocate Christ Medical Center/Advocate Children's Hospital.

Her areas of interest are in antimicrobial stewardship, infections in immunocompromised hosts, and clinical utility of MRSA surveillance screening.

Donald W. Johnson, Pharm.D., BCPS, BCCCP

Donald W. Johnson, Pharm.D., BCPS, BCCCP is a clinical specialist in trauma/surgical intensive care unit at UF Health Jacksonville and a Clinical Assistant Professor with the University of Florida College of Pharmacy.

Dr. Johnson received his Pharm.D. from the University of Florida College of Pharmacy. He completed his Pharmacy Practice residency (PGY-1) at UF Health Jacksonville and specialty residency in Critical Care (PGY-2) at UF Health Jacksonville. Dr. Johnson is faculty with The University of Florida College of Pharmacy where he is course coordinator for the Critical Care Pharmacy elective and a course facilitator for Dose Optimization I and II and Pharmacotherapy IV through VI. Dr. Johnson also serves as adjunct faculty for NOVA University for their Physician Assistant Program.

Dr. Johnson is an active member in the Society of Critical Care Medicine and is part of the clinical pharmacy and pharmacology education committee. He is a member of Northeast Florida Society of Health-System Pharmacists where he served as the treasurer. Dr. Johnson also volunteers with We Care Jacksonville and sits on the Young Professional Advisory Board. Dr. Johnson was awarded Preceptor of the Year by both Florida Society of Health-System Pharmacists and UF Health Jacksonville. Dr. Johnson also volunteers with We Care Jacksonville. Dr. Johnson was awarded Preceptor of the Year by both Florida Society of Health System Pharmacists and UF Health Jacksonville.

His areas of interest are in the use of 23.4% hypertonic saline in traumatic brain injury, music and sleep therapy in reducing ICU delirium and antibiotic stewardship strategies in the ICU.

Anthony M. Casapao, Pharm.D., M.P.H., FIDSA

Anthony M. Casapao, PharmD, MPH, FIDSA, is a Clinical Associate Professor at the University of Florida College of Pharmacy and a Clinical Infectious Diseases Pharmacotherapy Specialist at UF Health Jacksonville. He is a Health Care-Associated Infection Advisory Board Member at the Florida Department of Health.

He earned his Doctor of Pharmacy degree from Wingate University. He completed post-graduate pharmacy practice and infectious diseases residency training at St. Vincent’s Medical Center and the University of Pittsburgh Medical Center, respectively. He continued his love of infectious diseases by completing a fellowship at Wayne State University in Health Economics & Outcomes Research. He further developed his research skills by completing a master's degree in public health with a concentration in Epidemiology and Biostatistics at Harvard University.

His research focuses on pharmacoepidemiology, evaluating post-marketing data, and applying more extensive data to understand public health problems and explore possible solutions. He also focuses on the off-label use of antimicrobials with comparative effectiveness methodologies, expanding on previous subject knowledge, applying more robust data, and providing confirmatory conclusions for controversial data. His substantial research focuses on antimicrobial resistance and the clinical implications of anti-infective therapies from a One Health perspective.

Dr. Casapao has published extensively in peer-reviewed journals and is a Fellow of the Infectious Diseases Society of America. At the University of Florida, he teaches, mentors, and guides students through their professional development, particularly in infectious diseases.

Contact Information

Residency Coordinator
UF Health Jacksonville
Department of Pharmacy
655 West 8th Street, C-89
Jacksonville, FL 32209

Phone: (904) 244-4157
Fax: (904) 244-4272
E-mail: pharmacyresidency@jax.ufl.edu

After the application is complete and reviewed, the residency selection committee will notify selected applicants to arrange an onsite interview.